Cancer Immunology, Immunotherapy Issues Research Articles in August 2023 Edition
July 24, 2023
July 24, 2023
BASEL, Switzerland, July 24 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its August 2023 edition:
Review:
* Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases
Research:
* BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibi . . .
Review:
* Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases
Research:
* BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibi . . .